BioVoice News April 2017 Issue 11 Volume 1 | Page 34

bio chat Eliminating redundancies in the regulatory process and creating efficiency in the approval pathway is critical to ensure that the country realizes benefits of the current pipeline of high value vaccines How do you react to the statements that vaccine industry is a bubble created by lobbyists to earn bucks? There are also few who say that immunization campaigns is marketing for MNCs? There is global evidence on impact of vaccines in 34 BioVoiceNews | April 2017 reducing disease burden and the health economics are well established. In a high transmissibility environment such as India, vaccines are an import part of the Government’s arsenal to address the looming problem of communicable diseases. The polio vaccine success in India is globally recognized as a landmark effort that has successfully eradicated a once dreaded disease. While I strongly believe that public health stakeholders should not be deterred by such comments, I would also recommend that we adopt a data driven approach to putting any such concerns to rest. As a country, we